Rocket Lab (RKLB) CFO Exercise at $1.09; Sell-to-Cover Disposes ~874.6K Shares
Rhea-AI Filing Summary
Adam C. Spice, Rocket Lab Corp (RKLB) Chief Financial Officer, reported option exercises and share sales in mid-September 2025. On 09/18/2025 Mr. Spice exercised an employee stock option with a $1.09 exercise price covering 1,867,496 shares, triggering acquisition of those common shares. The filing reports a subsequent "sell-to-cover" disposition on 09/19/2025 of 862,588 shares at a weighted-average price of $47.9941 and an additional sale of 12,000 shares at a weighted-average price of $48.8484 to satisfy the exercise cost and tax withholding. After these transactions, the reporting person beneficially owned 3,254,155 shares including 1,867,496 underlying the exercised option and 2,057,889 shares held directly following the final sale.
Positive
- None.
Negative
- None.
Insights
TL;DR: CFO exercised long-dated options at $1.09 and sold a portion to cover costs, leaving substantial post-transaction ownership.
The exercise of 1,867,496 options with a $1.09 strike reflects long-term compensation vesting; the immediate sell-to-cover of 874,588 shares (aggregate) at ~ $48 per share is a routine tax-coverage disposition and reduces direct share count but leaves the CFO with 3,254,155 shares beneficially owned. This transaction is not an issuance or secondary financing event for the company; it is a personal liquidity action following option exercise and therefore has limited direct corporate financial impact. Investors may note insider liquidity but should treat this as routine compensation-related activity.
TL;DR: Transaction is a standard, disclosed officer exercise and sell-to-cover; compliance and disclosure appear complete.
The Form 4 discloses option grant details (original grant date August 3, 2018) and vesting schedule, exercise date, and weighted-average sale prices for shares sold to cover exercise and tax obligations. The filing includes an attorney-in-fact signature and explanatory footnotes describing the multi-trade weightings. From a governance and disclosure perspective, the form supplies the required particulars and footnote undertakings to furnish per-trade pricing on request, indicating adherence to reporting norms. No governance red flags or unusual concealment are evident in the document itself.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 862,588 | $47.9941 | $41.40M |
| Sale | Common Stock | 12,000 | $48.8484 | $586K |
| Exercise | Employee Stock Option (right to buy) | 1,867,496 | $0.00 | -- |
| Exercise | Common Stock | 1,867,496 | $1.09 | $2.04M |
Footnotes (1)
- Represents the sale of shares pursuant to a "sell-to-cover" transaction, with shares sold to cover the exercise price and satisfy applicable tax withholding obligations in connection with the exercise of stock options previously granted to the reporting person. The price reported in column 4 is a weighted average price of the aggregate number of shares. These shares were sold in multiple transactions in bulk at prices ranging from $47.7100 to $48.7000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in column 4 is a weighted average price of the aggregate number of shares. These shares were sold in multiple transactions in bulk at prices ranging from $48.7100 to $48.9300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock option was granted on August 3, 2018, and had a vesting commencement date of May 25, 2018. 1/4 of the shares subject to the stock option vest on the one year anniversary of the vesting commencement date, and 1/48 of the shares subject to the stock option vest on a monthly basis each month thereafter, subject, in each case, to the reporting person's continued service relationship through each applicable vesting date.
